Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > --------CHILLOUT----

<< Previous

Bullboard Posts

Next >>

Post by threefiftynineon Jul 08, 2020 1:10pm

125 Views

Post# 31240178

--------CHILLOUT----

We wont see this any higher than .105 today(JMHO) which is .02 cents above the offering ---until after the offering closes---and we find out what the heck this is all about----based on today , word is getting out---so the close of in and around the 17th is very very close------CAN'T YOU TELL---hero or zero -what's it to be

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 7, 2024